NPPB and cardiac hypertrophy: Cardiac hypertrophy-related MAPKs (e.g., p38, JNK and ERK1/2) and IL-6/MEK5/ERK5 signaling pathways were greatly activated, which resulted in the expression of pathologic hypertrophy response markers such as ANP and BNP in the heart of diabetic rats.